Αποτελέσματα Αναζήτησης
20 Μαΐ 2024 · What are the ingredients in ORTHO EVRA? Active ingredient: norelgestromin and ethinyl estradiol. Inactive ingredient: polyethylene, polyester, polyisobutylene/polybutene adhesive, crospovidone, non-woven polyester fabric, lauryl lactate, polyethylene terephthalate (PET) film, and polydimethylsiloxane coating.
6 Φεβ 2023 · Ortho Evra (norelgestromin/ethinyl estradiol) contains a combination of female hormones used as contraception to prevent pregnancy. What Are Side Effects of Ortho Evra? Ortho Evra may cause serious side effects including: hives, difficulty breathing, swelling of your face, lips, tongue, or throat,
ORTHO EVRA ® is a combination transdermal contraceptive patch with a contact surface area of 20 cm. 2. It contains 6.00 mg norelgestromin (NGMN) and 0.75 mg ethinyl estradiol (EE). Systemic...
Overview. This is a summary of the European public assessment report (EPAR) for Evra. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Evra.
23 Απρ 2024 · Generic name: norelgestromin 150ug in 1d, ethinyl estradiol 35ug in 1d. Dosage form: patch, extended release. Drug class: Contraceptives. Medically reviewed by Drugs.com. Last updated on Apr 23, 2024. To achieve maximum contraceptive effectiveness, ORTHO EVRA must be used exactly as directed.
Generic Allegra-D Approved. A combination of fexofenadine HCl and pseudoephedrine HCl in an extended-re-lease tablet (60 mg/120 mg) is indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and chil-dren 12 years and older.
SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE MEDICINAL PRODUCT. EVRA 203 micrograms/24 hours + 33.9 micrograms/24 hours transdermal patch. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION. Each 20 cm2 transdermal patch contains 6 mg norelgestromin (NGMN) and 600 micrograms ethinyl estradiol (EE).
